BRUSSELS OPENS ANTI-TRUST PROBE INTO CEPHALON AND TEVA
May 1st, 2011
BY KEITH NUTHALL
THE EUROPEAN Commission has opened a formal antitrust investigation assessing whether a deal between US-based pharmaceutical company Cephalon and Israeli generic drugs firm Teva restricting the sale of a sleeping medicine breaks EU restrictive business practice laws. Brussels will probe a 2005 agreement about the sale of the drug Modafinil where the companies settled patent infringement disputes in Britain and the United States. It involved Teva not selling its generic Modafinil products in the European Union (EU - plus Norway, Iceland and ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.